NDC 42291-464 – Telmisartan and Hydrochlorothiazide
Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet · Oral
Product NDC42291-464
Product details
- Brand name
- Telmisartan and Hydrochlorothiazide
- Generic name
- Telmisartan and Hydrochlorothiazide
- Labeler
- AvKARE
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA202544
- Marketed since
- June 18, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Angiotensin 2 Receptor Blocker; Thiazide Diuretic
Active ingredients
- Telmisartan 80 mg/1
- Hydrochlorothiazide 25 mg/1
Uses, dosage, side effects and warnings for Telmisartan And Hydrochlorothiazide →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 42291-464-30 | 3 BLISTER PACK in 1 BOX (42291-464-30) / 10 TABLET in 1 BLISTER PACK (42291-464-11) | Jun 18, 2024 |
Other Telmisartan And Hydrochlorothiazide products
- 62332-211 Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-209 Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 62332-210 Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Alembic Pharmaceuticals Inc.
- 46708-209 Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 46708-210 Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 46708-211 Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet · Alembic Pharmaceuticals Limited
- 65862-978 Telmisartan 80 mg/1; Hydrochlorothiazide 25 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-977 Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-976 Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Aurobindo Pharma Limited
- 42291-463 Telmisartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · AvKARE
- 42291-462 Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · AvKARE
- 68462-840 Telmisartan 40 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet · Glenmark Pharmaceuticals Inc., USA